Genotype and ancestry modulate brain's DAT availability in healthy humans

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Shumay, Elena ^a   Chen, John ^b   Fowler, Joanna S ^a   Volkow, Nora D ^c  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; SLC6A3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; GENE; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; INTRON; MALE; MESENCEPHALON; NEUROIMAGING; NORMAL HUMAN; PLESIOMORPHY; POSITRON EMISSION TOMOGRAPHY; PROTEIN AGGREGATION; SLC6A3 GENE; VARIABLE NUMBER OF TANDEM REPEAT; BRAIN; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSITRON-EMISSION TOMOGRAPHY; YOUNG ADULT;

EID: 79961069842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022754     Document Type: Article

References (70)

1. Monuteaux MC, Biederman J, Doyle AE, Mick E, Faraone SV, (2009) Genetic risk for conduct disorder symptom subtypes in an ADHD sample: specificity to aggressive symptoms. J Am Acad Child Adolesc Psychiatry 48: 757-764.
2. Caspi A, Langley K, Milne B, Moffitt TE, O'Donovan M, et al. (2008) A Replicated Molecular Genetic Basis for Subtyping Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry 65: 203-210.
3. Gottesman II, Gould TD, (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645.
4. Arias-Carrion O, Stamelou M, Murillo-Rodriguez E, Menendez-Gonzalez M, Poppel E, (2010) Dopaminergic reward system: a short integrative review. International Archives of Medicine 3: 24.
5. Shohamy D, Adcock RA, (2010) Dopamine and adaptive memory. Trends in Cognitive Sciences 14: 464-472.
6. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, et al. (2007) Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 17: 39-59.
7. Vernier P, Moret F, Callier S, Snapyan M, Wersinger C, et al. (2004) The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system. Ann N Y Acad Sci 1035: 231-249.
8. Lafuente A, Bernardo M, Mas S, Crescenti A, Aparici M, et al. (2007) Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics. Schizophr Res 90: 115-122.
9. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F, (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64: 1575-1579.
10. Eriksen J, Jorgensen TN, Gether U, (2010) Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. J Neurochem 113: 27-41.
11. Shumay E, Fowler JS, Volkow ND, (2010) Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity. PLoS One 5: e11067.
12. Mill J, Asherson P, Browes C, D'Souza U, Craig I, (2002) Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114: 975-979.
13. Fondon JW 3rd, Hammock EA, Hannan AJ, King DG, (2008) Simple sequence repeats: genetic modulators of brain function and behavior. Trends Neurosci 31: 328-334.
14. Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP, (2001) The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 79: 1033-1038.
15. Fuke S, Sasagawa N, Ishiura S, (2005) Identification and characterization of the Hesr1/Hey1 as a candidate trans-acting factor on gene expression through the 3′ non-coding polymorphic region of the human dopamine transporter (DAT1) gene. J Biochem 137: 205-216.
16. Greenwood TA, Kelsoe JR, (2003) Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82: 511-520.
17. van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Zoghbi SS, et al. (2002) Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry 10: 36-43.
18. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, et al. (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22: 133-139.
19. Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, et al. (2001) The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24: 553-560.
20. van de Giessen EM, de Win MM, Tanck MW, van den Brink W, Baas F, et al. (2009) Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 50: 45-52.
21. Asherson P, Brookes K, Franke B, Chen W, Gill M, et al. (2007) Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry 164: 674-677.
22. Brookes KJ, Neale BM, Sugden K, Khan N, Asherson P, et al. (2007) Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue. Am J Med Genet B Neuropsychiatr Genet 144B: 1070-1078.
23. Hill M, Anney RJ, Gill M, Hawi Z, (2010) Functional analysis of intron 8 and 3′ UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants. Pharmacogenomics J 10 (5): 442-7.
24. Guindalini C, Martins RC, Andersen ML, Tufik S, (2010) Influence of genotype on dopamine transporter availability in human striatum and sleep architecture. Psychiatry Res 179 (2): 238-40.
25. Fowler JS, Volkow ND, Logan J, Alexoff D, Telang F, et al. (2008) Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine. Neuroimage 43: 756-763.
26. Kang AM, Palmatier MA, Kidd KK, (1999) Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 46: 151-160.
27. Mattei J, Parnell LD, Lai CQ, Garcia-Bailo B, Adiconis X, et al. (2009) Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites. BMC Genet 10: 45.
28. Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B, et al. (1992) Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc Natl Acad Sci U S A 89: 7095-7099.
29. Bannon MJ, Whitty CJ, (1997) Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology 48: 969-977.
30. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, et al. (1996) Dopamine transporters decrease with age. J Nucl Med 37: 554-559.
31. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, et al. (2007) Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 34: 1182-1190.
32. Wang GJ, Chang L, Volkow ND, Telang F, Logan J, et al. (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127: 2452-2458.
33. Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, et al. (2009) Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. Jama 301: 1148-1154.
34. Smith Y, Kieval JZ, (2000) Anatomy of the dopamine system in the basal ganglia. Trends Neurosci 23: S28-33.
35. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, et al. (2009) Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 5: e1000602.
36. Volkow ND, Wang G-J, Fowler JS, Ding Y-S, (2005) Imaging the Effects of Methylphenidate on Brain Dopamine: New Model on Its Therapeutic Actions for Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry 57: 1410-1415.
37. Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, et al. (2009) Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment. Neuroimage 45: 1232-1240.
38. Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, et al. (2008) Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 42: 1537-1543.
39. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, et al. (2007) Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64: 932-940.
40. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, et al. (2002) Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43: 181-187.
41. Fowler JS, Volkow ND, Wang GJ, Gatley SJ, Logan J, (2001) [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy. Nucl Med Biol 28: 561-572.
42. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, et al. (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16: 834-840.
43. Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, et al. (2000) Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry 5: 283-292.
44. Guindalini C, Howard M, Haddley K, Laranjeira R, Collier D, et al. (2006) A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc Natl Acad Sci U S A 103: 4552-4557.
45. Rodriguez S, Gaunt TR, Day IN, (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169: 505-514.
46. Excoffier L, Slatkin M, (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12: 921-927.
47. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, et al. (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14: 1104-1106.
48. Genro JP, Polanczyk GV, Zeni C, Oliveira AS, Roman T, et al. (2008) A common haplotype at the dopamine transporter gene 5′ region is associated with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B: 1568-1575.
49. International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437: 1299-1320.
50. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, et al. (2000) Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 157: 1700-1703.
51. Guo G, Tong Y, Xie CW, Lange LA, (2007) Dopamine transporter, gender, and number of sexual partners among young adults. Eur J Hum Genet 15: 279-287.
52. Epstein LH, Jaroni JL, Paluch RA, Leddy JJ, Vahue HE, et al. (2002) Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obes Res 10: 1232-1240.
53. Rommelse NN, Altink ME, Arias-Vasquez A, Buschgens CJ, Fliers E, et al. (2008) A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD. Am J Med Genet B Neuropsychiatr Genet 147B: 1536-1546.
54. Khusnutdinova EK, Viktorova TV, Akhmetova VL, Mustafina OE, Fatkhlislamova RI, et al. (2003) [Population-genetic structure of Chuvashia (from data on eight DNA loci in the nuclear genome)]. Genetika 39: 1550-1563.
55. Keinan A, Mullikin JC, Patterson N, Reich D, (2007) Measurement of the human allele frequency spectrum demonstrates greater genetic drift in East Asians than in Europeans. Nat Genet 39: 1251-1255.
56. Benedek G, Paperna T, Avidan N, Lejbkowicz I, Oksenberg JR, et al. (2010) Opposing effects of the HLA-DRB1[ast]0301-DQB1[ast]0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel. Genes Immun 11: 423-431.
57. Yang B, Chan RC, Jing J, Li T, Sham P, et al. (2007) A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144B: 541-550.
58. Ballon N, Leroy S, Roy C, Bourdel MC, Olie JP, et al. (2007) Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3′ UTR VNTR of the DAT: Association with childhood ADHD in male African-Caribbean cocaine dependents? American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144B: 1034-1041.
59. Drgon T, Lin Z, Wang GJ, Fowler J, Pablo J, et al. (2006) Common human 5′ dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo. Cell Mol Neurobiol 26: 875-889.
60. Júlia PG, Guilherme VP, Cristian Z, Angélica SO, Tatiana R, et al. (2008) A common haplotype at the dopamine transporter gene 5prime region is associated with attention-deficit/hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B: 1568-1575.
61. Brookes KJ, Xu X, Anney R, Franke B, Zhou K, et al. (2008) Association of ADHD with genetic variants in the 5prime-region of the dopamine transporter gene: Evidence for allelic heterogeneity. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B: 1519-1523.
62. Cohen ME, Cecil JC, (1983) Applicability of multiple covariance analysis in caries studies. Community Dent Oral Epidemiol 11: 102-104.
63. Elena SF, Sanjuan R, (2003) Evolution. Climb every mountain? Science 302: 2074-2075.
64. Martin GM, (2002) Gene action in the aging brain: an evolutionary biological perspective. Neurobiol Aging 23: 647-654.
65. Ritz BR, Manthripragada AD, Costello S, Lincoln SJ, Farrer MJ, et al. (2009) Dopamine transporter genetic variants and pesticides in Parkinson's disease. Environ Health Perspect 117: 964-969.
66. D'Souza UM, Craig IW, (2008) Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders. Prog Brain Res 172: 73-98.
67. Ball EV, Stenson PD, Abeysinghe SS, Krawczak M, Cooper DN, et al. (2005) Microdeletions and microinsertions causing human genetic disease: common mechanisms of mutagenesis and the role of local DNA sequence complexity. Hum Mutat 26: 205-213.
68. Tan IK, Mackin L, Wang N, Papenfuss AT, Elso CM, et al. (2010) A recombination hotspot leads to sequence variability within a novel gene (AK005651) and contributes to type 1 diabetes susceptibility. Genome Res 20: 1629-1638.
69. Fuchs SC, Guimaraes SM, Sortica C, Wainberg F, Dias KO, et al. (2002) Reliability of race assessment based on the race of the ascendants: a cross-sectional study. BMC Public Health 2: 1.
70. Campbell CD, Ogburn EL, Lunetta KL, Lyon HN, Freedman ML, et al. (2005) Demonstrating stratification in a European American population. Nat Genet 37: 868-872.